Environmental risk factors in systemic sclerosis

Current Opinion in Rheumatology

Volumn 25, Issue 2, 2013, Pages 179-183

  Dospinescu, Paula ^a   Jones, Gareth T ^a   Basu, Neil ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

epidemiology; silica; solvents; systemic sclerosis

Indexed keywords

ACETONE; DNA TOPOISOMERASE; EPOXY RESIN; ORGANIC SOLVENT; SILICON DIOXIDE; TOLUENE; TOXIN; TRICHLOROETHYLENE; XYLENE;

BREAST SURGERY; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FOLLOW UP; HAND ARM VIBRATION; HUMAN; META ANALYSIS (TOPIC); NONHUMAN; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; RAYNAUD PHENOMENON; REVIEW; RISK FACTOR; SCLERODERMA; SILICONE BREAST IMPLANT; SKIN ATROPHY; SMOKING; SOCIAL STATUS; SYSTEMIC SCLEROSIS; WELDING FUME;

ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; OCCUPATIONAL EXPOSURE; RISK FACTORS; SCLERODERMA, SYSTEMIC; SILICON DIOXIDE; SOLVENTS;

EID: 84873407864     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32835cfc2d     Document Type: Review

References (38)

1. Barnes J, Mayes MD. Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers. Curr Opin Rheumatol 2012; 24:165-170.
2. Steen VD, Medsger TA Jr. Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 2001; 44:2828-2835.
3. Gorlova O, Martin JE, Rueda B, et al. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet 2011; 7:e1002178.
4. Cooper GS, Miller FW, Germolec DR. Occupational exposures and auto-immune diseases. Int Immunopharmacol 2002; 2:303-313.
5. Gold LS, Ward MH, Dosemeci M, De Roos AJ. Systemicautoimmunedisease mortality and occupational exposures. Arthritis Rheum 2007; 56:3189-3201.
6. Smith V, Vanthuyne M, Vander Cruyssen B, et al. Over-representation of construction-related occupations in male patients with systemic sclerosis. Ann Rheum Dis 2008; 67:1448-1450.
7. Englert H, Small-McMahon J, Davis K, et al. Male systemic sclerosis and occupational silica exposure-a population-based study. Aust N Z J Med 2000; 30:215-220.
8. Aryal BK, Khuder SA, Schaub EA. Meta-analysis of systemic sclerosis and exposure to solvents. Am J Ind Med 2001; 40:271-274.
9. Bramwell B. Diffuse scleroderma: its frequency; its occurrence in stonemasons, its treatment by fibrinolysis: elevations of temperature due to fibrinolysis injections. Edinburgh Med J 1914; 12:387-401.
10. Erasmus LD. Scleroderma in goldminersontheWitwatersrandwith particular reference to pulmonary manifestations. S Afr J Lab Clin Med 1957; 3:209-231.
11. Rodnan GP, Benedek TG, Medsger TA Jr, Cammarata RJ. The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoco-niosis and other forms of silicosis. Ann Intern Med 1967; 66:323-334.
12. Moisan S, Rucay P, Ghali A, et al. Silica-associated limited systemic sclerosis after occupational exposure to calcined diatomaceous earth. Joint Bone Spine 2010; 77:472-473.
13. McCormic ZD, Khuder SS, Aryal BK, et al. Occupational silica exposure as a risk factor for scleroderma: a meta-analysis. Int Arch Occup Environ Health 2010; 83:763-769.
14. Diot E, Lesire V, Guilmot JL, et al. Systemic sclerosis and occupational risk factors: a case-control study. Occup Environ Med 2002; 59:545-549.
15. Slimani S, Ben Ammar A, Ladjouze-Rezig A. Connective tissue diseases after heavy exposure to silica: a report of nine cases in stonemasons. Clin Rheumatol 2010; 29:531-533.
16. Sluis-Cremer GK, Hessel PA, Nizdo EH, et al. Silica, silicosis, and progressive systemic sclerosis. Br J Ind Med 1985; 42:838-843.
17. Calvert GM, Rice FL, Boiano JM, et al. Occupational silicaexposureand riskof various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 2003; 60:122-129.
18. Parks CG, Conrad K, Cooper GS. Occupational exposure to crystalline silica and autoimmune disease. Environmental health perspectives 1999; 107 (Suppl 5):793-802.
19. Brown JM, Pfau JC, Holian A. Immunoglobulin and lymphocyte responses following silicaexposure in New Zealand mixed mice. Inhalation Toxicol 2004; 16:133-139.
20. Reinl W. Scleroderma caused by trichloroethylene effects. Zentralblatt fur Arbeitsmedizin und Arbeitsschutz 1957; 7:58-60.
21. Thompson AE, Pope JE. Increased prevalence of scleroderma in south-western Ontario: a cluster analysis. J Rheumatol 2002; 29:1867-1873.
22. Bovenzi M, Barbone F, Pisa FE, et al. A case-control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health 2004; 77:10-16.
23. Garabrant DH, Lacey JV Jr, Laing TJ, et al. Scleroderma and solvent exposure among women. Am J Epidemiol 2003; 157:493-500.
24. Maitre A, Hours M, Bonneterre V, et al. Systemic sclerosis and occupational risk factors: role of solvents and cleaning products. J Rheumatol 2004; 31:2395-2401.
25. Kutting B, Uter W, Drexler H. Is occupational exposure to solvents associated with an increased risk for developing systemic scleroderma? J Occup Med Toxicol 2006; 1:15.
26. Kettaneh A, Al Moufti O, Tiev KP, et al. Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies. J Rheumatol 2007; 34:97-103.
27. Nietert PJ, Sutherland SE, Silver RM, et al. Is occupational organic solvent exposurea riskfactorforscleroderma? Arthritis Rheum 1998; 41:1111-1118.
28. Purdie GL, Purdie DJ, Harrison AA. Raynaud's phenomenon in medical labora-tory workers who workwith solvents. J Rheumatol 2011; 38:1940-1946.
29. Spencer-Green G. Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 1998; 158:595-600.
30. Koenig M, Joyal F, Fritzler MJ, et al. Autoantibodies and microvascular damage are independent predictivefactorsforthe progression of Raynaud's phenom-enon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008; 58:3902-3912.
31. Magnant J, de Monte M, Guilmot JL, et al. Relationship between occupational risk factors and severity markers of systemic sclerosis. J Rheumatol 2005; 32:1713-1718.
32. Silman AJ, Jones S. What is the contribution of occupational environmental factors to the occurrence of scleroderma in men? Ann Rheum Dis 1992; 51:1322-1324.
33. Bovenzi M, Barbone F, Pisa FE, et al. Scleroderma and occupational exposure to hand-transmitted vibration. Int Arch Occup Environ Health 2001; 74:579-582.
34. Janowsky EC, Kupper LL, Hulka BS. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med 2000; 342:781-790.
35. Levy Y, Rotman-Pikielny P, Ehrenfeld M, Shoenfeld Y. Silicone breast im-plantation-induced scleroderma: description of four patients and a critical review of the literature. Lupus 2009; 18:1226-1232.
36. Hudson M, Lo E, Lu Y, et al. Cigarette smoking in patients with systemic sclerosis. Arthritis Rheum 2011; 63:230-238.
37. Hissaria P, Roberts-Thomson PJ, Lester S, et al. Cigarettesmoking in patients with systemic sclerosis reduces overall survival: comment on the article by Hudson et al. Arthritis Rheum 2011; 63:1758-1759.
38. Gyger G, Hudson M, Lo E, et al. Does cigarette smoking mitigate the severity of skin disease in systemic sclerosis? Rheumatol Int 2012 [Epub doi: 10. 1007/s00296-012-2481-6].